NIH-funded research R01 grant

Understanding how immune and skin cells work together to repair wounds in living animals

Official title: Understanding immune-epithelial interactions during wound repair in live mammals

Funded at Michigan State University · NIH-11416626 · Data updated 2026-11-12

This NIH grant looks at how skin and immune cells cooperate to restore the skin barrier after injury, with the goal of better healing and preventing cancer progression.

More Wound research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionMichigan State University
NIH-funded
Lab location1 site (East Lansing, United States)
Project startSeptember 15, 2023
Project endJuly 31, 2028
Funding year2026
Award (this year)$476,364
NIH project number5R01AR083086-04
Project IDNIH-11416626 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates are patients with chronic or complicated wounds where skin healing is impaired or at risk of cancer progression, to inform future translational approaches.

Less likely to help

Individuals without chronic wounds or skin healing issues may see no direct benefit.

What this research studies

The project studies how Langerhans cells and other immune cells interact with skin cells during wound repair in live mammals. Researchers will explore cellular communication and behavior to understand how the epidermis regains its protective barrier. Findings could point to new treatments for acute and chronic wounds that reduce infection risk and future cancer development. The work involves animal models and aims to translate insights into therapies that help patients heal faster and more completely.

Why it matters

Potential benefit: If successful, the research could lead to therapies that improve wound healing and reduce progression to cancer in people with chronic skin wounds.

How similar studies have gone: Previous studies have shown roles for skin immune cells in healing, but the specific LC-epithelial interactions during repair are not fully understood and could yield novel targets.

Where this research is happening

  • Michigan State University
    East Lansing, United States
    Active

Researchers

  • Principal investigator: Park, Sangbum — Michigan State University
  • Study coordinator: Park, Sangbum

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.